Catharine Young calls a glioblastoma development “remarkable” and uses it to argue for funding science, emphasizing the cancer’s aggressiveness and lethality.
Having worked in this field, I cannot overstate how remarkable this is.
Glioblastoma is one of the most aggressive, deadly brain cancers we know.
THIS is why we fund science.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare